QWO is the first and only approved injectable for the reduction of moderate to severe cellulite. Studies have shown visible results within 10 weeks. Most women receive 3 treatments every 21 days. As we age, our skin thins and fat cells enlarge and begin to push against the skin. Then, the fibrous bands under the skin thicken and cause tension resulting in dimples. After your QWO treatment there is no down-time and patients may experience some bruising that should resolve on it’s own.
Kybella™ is the first FDA-approved injectable drug that targets submental fullness, often referred to as a “double chin”. Bellaire Dermatology was one of the first practices to offer this revolutionary treatment to solve an issue that bothers 68% of consumers. As one of the first providers to offer the Kybella™ treatment, our physicians are highly trained in patient assessment and administration of Kybella™ for optimal results. A treatment plan will be tailored to each patient to achieve the desired improvement in submental fullness.
The Cellfina™ System is the only FDA-cleared minimally invasive procedure clinically proven to improve the appearance of cellulite for at least two years—the longest FDA-cleared duration for a cellulite treatment. An outpatient procedure offered through a qualified physician, Cellfina™ combines a proven approach with innovative technology to treat the primary structural cause of cellulite. The result is a smooth look that gives patients the confidence to wear a bathing suit and higher hemlines.